MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 46 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $132,536,000 | +124.7% | 111,960,000 | +85.5% | 0.13% | +136.4% |
| Q2 2019 | $58,974,000 | +174.4% | 60,370,000 | +135.9% | 0.06% | +161.9% |
| Q1 2019 | $21,495,000 | +26.3% | 25,590,000 | +12.3% | 0.02% | +10.5% |
| Q4 2018 | $17,024,000 | -6.6% | 22,795,000 | +14.3% | 0.02% | +11.8% |
| Q3 2018 | $18,230,000 | +62.5% | 19,950,000 | +78.1% | 0.02% | +54.5% |
| Q2 2018 | $11,219,000 | +3.3% | 11,200,000 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $10,857,000 | +4.1% | 11,200,000 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $10,433,000 | -11.5% | 11,200,000 | 0.0% | 0.01% | -20.0% |
| Q3 2017 | $11,793,000 | +37.6% | 11,200,000 | +38.0% | 0.01% | +25.0% |
| Q2 2017 | $8,568,000 | – | 8,115,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |